The Diabetes Educator

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to register today!

Click here to register today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nielsen, S.
Right arrow Articles by Dandona, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nielsen, S.
Right arrow Articles by Dandona, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
The Diabetes Educator, Vol. 31, No. 6, 843-848 (2005)
DOI: 10.1177/0145721705283078
© 2005 American Association of Diabetes Educators; Published by SAGE Publications

FEATURES

Use of Continuous Subcutaneous Insulin Infusion Pump in Patients With Type 2 Diabetes Mellitus

Susan Nielsen, MS, ANP, CDE, Donna Kain, BSN, RN, MSEd, Elizabeth Szudzik, MS, RD, CND, CDE, Sandeep Dhindsa, MD, Rajesh Garg, MD and Paresh Dandona, MD, DPhil, FRCP, FACP, FACC

From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New York.

Correspondence to Paresh Dandona, MD, DPhil, FRCP, FACP, FACC, Millard Fillmore Hospital, 3 Gates Circle, Buffalo, NY 14209 (pdandona{at}kaleidahealth.org).

Purpose

In patients with type 2 diabetes, the control of hyperglycemia is often difficult despite full doses of oral hypoglycemic agents and extremely large doses of insulin. These patients pose a major management problem. The authors therefore investigated whether insulin given as a subcutaneous continuous infusion of insulin (CSII) would result in an improvement in glucose homeostasis.

Methods

Four patients with badly controlled type 2 diabetes, on treatment with extremely high doses of insulin and oral hypoglycemic agents, were started on CSII.

Results

All four patients had a marked improvement in plasma glucose concentrations with a corresponding fall in HbA1c levels. This improvement was associated with a marked fall in the insulin doses necessary to maintain adequate glucose homeostasis.

Conclusions

Since HbA1c levels fell from levels that would be associated with diabetic complications to those at which complications are markedly reduced, we recommendthat patients with type 2 diabetes uncontrolled on extremely high doses of insulin be given a trial of treatment with CSII.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Clin. DiabetesHome page
J. S. Skyler, S. Ponder, D. F. Kruger, D. Matheson, and C. G. Parkin
Is There a Place for Insulin Pump Therapy in Your Practice?
Clin. Diabetes, April 1, 2007; 25(2): 50 - 56.
[Abstract] [Full Text] [PDF]